Average Co-Inventor Count = 9.64
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (55 from 1,979 patents)
55 patents:
1. 12473289 - Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
2. 12440491 - KRAS G12C inhibitors and methods of using the same
3. 12083121 - Substituted piperazines as KRAS G12C inhibitors
4. 11993597 - Inhibitors of KRAS G12C and methods of using the same
5. 11766436 - KRAS G12C inhibitors and methods of using the same
6. 11548903 - Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
7. 11306087 - Inhibitors of KRAS G12C and methods of using the same
8. 11285156 - Substituted piperazines as KRAS G12C inhibitors
9. 11096939 - KRAS G12C inhibitors and methods of using the same
10. 11090304 - KRAS G12C inhibitors and methods of using the same
11. 11046680 - Heteroaryl-substituted triazoles as APJ receptor agonists
12. 11045484 - KRAS G12C inhibitors and methods of using the same
13. 11021493 - 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
14. 10947223 - Substituted oxazines as beta-secretase inhibitors
15. 10906890 - Triazole phenyl compounds as agonists of the APJ receptor